BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients: Journal of ECT

E. Maffioletti, M. Gennarelli, G. Gainelli, L. Bocchio-Chiavetto, M. Bortolomasi, A. Minelli

Research output: Contribution to journalArticlepeer-review

Abstract

Objectives Electroconvulsive therapy (ECT) represents one of the most effective therapies for treatment-resistant depression (TRD). The brain-derived neurotrophic factor (BDNF) is a neurotrophin implicated in major depressive disorder and in the effects of different therapeutic approaches, including ECT. Both BDNF peripheral levels and Val66Met polymorphism have been suggested as biomarkers of treatment effectiveness. The objective of this study was to test the potential of serum BDNF levels and Val66Met polymorphism in predicting ECT outcome in TRD patients. Methods Seventy-four TRD patients scheduled to undergo ECT were included in the study. Illness severity was assessed through the Montgomery and Asberg Depression Rating Scale before beginning ECT (T0), the day after the end of ECT (T1), and 1 month after the end of ECT (T2). At T1, patients were classified as responders/nonresponders and remitters/nonremitters, whereas at T2, they were classified as sustained responders/nonresponders and sustained remitters/nonremitters. Serum concentrations of BDNF were measured at T0, and the BDNF Val66Met polymorphism was genotyped. Results No difference in BDNF concentrations was observed in responders versus nonresponders, in remitters versus nonremitters, in sustained responders versus sustained nonresponders, and in sustained remitters versus sustained nonremitters. No association of Val66Met polymorphism was detected with both the response and the remission status. Conclusions Baseline serum BDNF levels and the BDNF Val66Met polymorphism showed no clinical utility in predicting ECT outcome in TRD patients. © Wolters Kluwer Health, Inc. All rights reserved.
Original languageEnglish
Pages (from-to)189-194
Number of pages6
JournalJournal of Ecology
Volume35
Issue number3
DOIs
Publication statusPublished - 2019

Keywords

  • BDNF
  • biomarker
  • brain-derived
  • depression
  • ECT, treatment-resistant
  • electroconvulsive therapy
  • neurotrophic factor
  • predictive
  • rs6265
  • single-nucleotide polymorphism
  • SNP
  • TRD
  • Val66Met

Fingerprint

Dive into the research topics of 'BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients: Journal of ECT'. Together they form a unique fingerprint.

Cite this